Phase 1, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess Potential Interactions Between Intravenous Cocaine and Oral SXC-2023
Latest Information Update: 27 May 2025
At a glance
- Drugs SXC-2023 (Primary) ; Cocaine
- Indications Impulse control disorders
- Focus Adverse reactions
Most Recent Events
- 20 May 2025 Status changed from recruiting to completed.
- 13 Nov 2024 Status changed from not yet recruiting to recruiting.
- 05 Apr 2024 New trial record